Renal cell carcinoma guideline

被引:469
作者
Ljungberg, Borje [1 ]
Hanbury, Damian C.
Kuczyk, Marcus A.
Merseburger, Axel S.
Mulders, Peter F. A.
Patard, Jean-Jacques
Sinescu, Ioanel C.
机构
[1] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, S-90185 Umea, Sweden
[2] Lister Hosp, Dept Urol, Stevenage, Herts, England
[3] Univ Tubingen, Dept Urol, Tubingen, Germany
[4] Radboud Univ Nijmegen, Med Ctr, Dept Urol, Nijmegen, Netherlands
[5] CHU Pontchaillou, Dept Urol, Rennes, France
[6] Fundeni Clin Inst, Dept Urol & Kidney Transplantat, Bucharest, Romania
关键词
diagnosis; follow-up; recommendations; guidelines; renal cell carcinoma; treatment;
D O I
10.1016/j.eururo.2007.03.035
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The European Association of Urology (EAU) Guideline Group for renal cell carcinoma (RCC) prepared this guideline to help urologists assess the evidence-based management of RCC and to incorporate the guideline recommendations into their clinical practice. Methods: The recommendations provided in the current guideline are based on a systematic literature search using Medline, the Cochrane Central Register of Controlled Trials, and publications and review articles. Results: A limited number of prospective randomised. studies are available with high-level evidence. Most publications concerning RCC are based on retrospective analyses, including some larger multicentre validation studies and well-designed controlled studies. Conclusions: It must be stressed that the current guideline contains information for the treatment of an individual patient according to a standardised general approach. Updated recommendations concerning diagnosis, treatment, and follow-up can improve the clinical handling of patients with RCC. (C) 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1502 / 1510
页数:9
相关论文
共 65 条
[1]   Randomized phase II/III trial of interferon alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell carcinoma:: The European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951) [J].
Aass, N ;
De Mulder, PHM ;
Mickisch, GHJ ;
Mulders, P ;
van Oosterom, AT ;
van Poppel, H ;
Fossa, SD ;
de Prijck, L ;
Sylvester, RJ .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) :4172-4178
[2]   Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial [J].
Andrews, DW ;
Scott, CB ;
Sperduto, PW ;
Flanders, AE ;
Gaspar, LE ;
Schell, MC ;
Werner-Wasik, M ;
Demas, W ;
Ryu, J ;
Bahary, JP ;
Souhami, L ;
Rotman, M ;
Mehta, MP ;
Curran, WJ .
LANCET, 2004, 363 (9422) :1665-1672
[3]  
[Anonymous], [No title captured]
[4]  
[Anonymous], EUR VERS 4 0 EUR INC
[5]   IL-2 in combination with IFN-α and 5-FU versus tamoxifen in metastatic renal cell carcinoma:: long-term results of a controlled randomized clinical trial [J].
Atzpodien, J ;
Kirchner, H ;
Illiger, HJ ;
Metzner, B ;
Ukena, D ;
Schott, H ;
Funke, PJ ;
Gramatzki, M ;
von Jürgensom, S ;
Wandert, T ;
Patzelt, T ;
Reitz, M .
BRITISH JOURNAL OF CANCER, 2001, 85 (08) :1130-1136
[6]   Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma:: Long-term survival data of 216 patients [J].
Becker, F ;
Siemer, S ;
Humke, U ;
Hack, M ;
Ziegler, M ;
Stöckle, M .
EUROPEAN UROLOGY, 2006, 49 (02) :308-313
[7]   Morphologic typing of papillary renal cell carcinoma: Comparison of growth kinetics and patient survival in 66 cases [J].
Delahunt, B ;
Eble, JN ;
McCredie, MRE ;
Bethwaite, PB ;
Stewart, JH ;
Bilous, AM .
HUMAN PATHOLOGY, 2001, 32 (06) :590-595
[8]  
Eble JN, 2004, PATHOLOGY GENETICS T, P7
[9]   Sorafenib in advanced clear-cell renal-cell carcinoma [J].
Escudier, Bernard ;
Eisen, Tim ;
Stadler, Walter M. ;
Szczylik, Cezary ;
Oudard, Stephane ;
Siebels, Michael ;
Negrier, Sylvie ;
Chevreau, Christine ;
Solska, Ewa ;
Desai, Apurva A. ;
Rolland, Frederic ;
Demkow, Tomasz ;
Hutson, Thomas E. ;
Gore, Martin ;
Freeman, Scott ;
Schwartz, Brian ;
Shan, Minghua ;
Simantov, Ronit ;
Bukowski, Ronald M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :125-134
[10]   Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma [J].
Ficarra, V ;
Schips, L ;
Guillé, F ;
Li, GR ;
De la Taille, A ;
Galetti, TP ;
Cindolo, L ;
Novara, G ;
Zigeuner, RE ;
Bratti, E ;
Tostain, J ;
Altieri, V ;
Abbou, CC ;
Artibani, W ;
Patard, JJ .
CANCER, 2005, 104 (05) :968-974